Effects of dihydroartemisinin on proliferation and apoptosis of human triple-negative breast cancer MDA-MB-231 cells based on PI3K/AKT signaling pathway
Experiment Research|更新时间:2022-09-09
|
Effects of dihydroartemisinin on proliferation and apoptosis of human triple-negative breast cancer MDA-MB-231 cells based on PI3K/AKT signaling pathway
Academic Journal of Shanghai University of Traditional Chinese MedicineVol. 35, Issue 6, Pages: 49-57(2021)
XU Jiaruo, CHEN Jialiang, YAO Guangtao. Effects of dihydroartemisinin on proliferation and apoptosis of human triple-negative breast cancer MDA-MB-231 cells based on PI3K/AKT signaling pathway. [J]. Academic Journal of Shanghai University of Traditional Chinese Medicine 35(6):49-57(2021)
DOI:
XU Jiaruo, CHEN Jialiang, YAO Guangtao. Effects of dihydroartemisinin on proliferation and apoptosis of human triple-negative breast cancer MDA-MB-231 cells based on PI3K/AKT signaling pathway. [J]. Academic Journal of Shanghai University of Traditional Chinese Medicine 35(6):49-57(2021) DOI: 10.16306/j.1008-861x.2021.06.008.
Effects of dihydroartemisinin on proliferation and apoptosis of human triple-negative breast cancer MDA-MB-231 cells based on PI3K/AKT signaling pathway
Objective:,2,To investigate the effects of dihydroartemisinin(DHA) on the proliferation and apoptosis of human triple-negative breast cancer MDA-MB-231 cells based on PI3K/AKT signaling pathway.,Methods:,2,①After treatment with DHA at different concentrations(25, 50, 100 μmol/L) for different times(12, 24, 48, 72 h), the cell proliferation was detected by MTT assay.②After treatment with DHA at different concentrations(0, 30, 60, 90 μmol/L) for 48 hours, the cell apoptosis and cell cycle were detected by flow cytometry, and the cell apoptosis was observed by Hoechst 33258 staining.③The effect of 60 μmol/L DHA on the cell migration was observed by scratch test after treatment for 0, 6, 12 and 24 hours respectively.④After treatment with DHA at 60 μmol/L for 12 hours, the mRNA expression levels of apoptosis related factors ,Caspase-3,Caspase-9,Bcl-2, and ,Bax, were detected by PCR.After treatment with DHA at 60 μmol/L for 48 hours, the protein expression levels of Caspase-3, Caspase-9, Bcl-2, Bax, PI3K, p-PI3K, AKT and p-AKT were detected by Western blot.,Results:,2,①DHA could inhibit the proliferation of MDA-MB-231 cells, and the inhibitory effect was increased with the increase of drug concentration.②DHA could promote the apoptosis of MDA-MB-231 cells, and this effect was increased with the increase of drug concentration.③DHA at 30 μmol/L could block the cell cycle in G0/G1 phase, and DHA at 60 and 90 μmol/L could block the cell cycle in G2/M phase.④After treatment with DHA at 60 μmol/L for 12 and 24 hours, the cell migration rate was decreased significantly(,P,<,0.01) .⑤After treatment with DHA at 60 μmol/L, the expression levels of ,Caspase-3, and ,Caspase-9, mRNA and the expression ratio of ,Bax/Bcl-2, mRNA were significantly up-regulated(,P,<,0.01), and the expression ratios of cleaved Caspase-9/Caspase-9 and Bax/Bcl-2 protein were significantly increased(,P,<,0.05) ; meanwhile, the protein expression level of PI3K was increased significantly(,P,<,0.05), and the protein expression levels of p-PI3K and p-AKT were decreased significantly(,P,<,0.01) .,Conclusion:,2,DHA may inhibit the proliferation and migration of MDA-MB-231 cells and induce the cell apoptosis by inhibiting PI3K/AKT signaling pathway.
关键词
双氢青蒿素三阴性乳腺癌细胞增殖细胞凋亡PI3K/AKT信号通路MDA-MB-231细胞
Keywords
dihydroartemisinintriple-negative breast cancercell proliferationcell apoptosisPI3K/AKT signaling pathwayMDA-MB-231 cell
references
SUNG H,FERLAY J,SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2021,71(3):209-249.
COSTA R L,HAN H S,GRADISHAR W J. Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer:a review[J]. Breast Cancer Res Treat,2018,169(3):397-406.
SCHMADEKA R,HARMON B E,SINGH M. Triple-negative breast carcinoma:current and emerging concepts[J]. Am J Clin Pathol,2014,141(4):462-477.
BIANCHINI G,BALKO M J,MAYER A I, et al. Triple-negative breast cancer: challenges and opportunities of a heterogeneous disease[J]. Nat Rev Clin Oncol,2016,13(11):674-690.
PARK J H,AHN J H,KIM S B. How shall we treat early triple-negative breast cancer(TNBC):from the current standard to upcoming immuno-molecular strategies[J]. ESMO Open,2018,3(Suppl 1):e000357.
LIANG R,CHEN W,CHEN X Y, et al. Dihydroartemisinin inhibits the tumorigenesis and invasion of gastric cancer by regulating STAT1/KDR/MMP9 and P53/BCL2L1/CASP3/7 pathways[J]. Pathol Res Pract,2021,218:153318.
ZHU L,CHEN X,ZHU Y, et al. Dihydroartemisinin Inhibits the Proliferation of Esophageal Squamous Cell Carcinoma Partially by Targeting AKT1 and p70S6K[J]. Front Pharmacol,2020,11:587470.
LIU Y,WANG W,XU J, et al. Dihydroartemisinin inhibits tumor growth of human osteosarcoma cells by suppressing Wnt/β-catenin signaling[J]. Oncol Rep,2013,30(4):1723-1730.
ZHU W H,LI Y W,ZHAO D H, et al. Dihydroartemisinin suppresses glycolysis of LNCaP cells by inhibiting PI3K/AKT pathway and downregulating HIF-1α expression[J]. Life Sci,2019,233:116730.
LI X G,BA Q,LIU Y L, et al. Dihydroartemisinin selectively inhibits PDGFRα-positive ovarian cancer growth and metastasis through inducing degradation of PDGFRα protein[J]. Cell Discov,2017,3(1):17042.
LI Y Q,WANG W,LI A X, et al. Dihydroartemisinin induces pyroptosis by promoting the AIM2/caspase-3/DFNA5 axis in breast cancer cells[J]. Chem Biol Interact,2021,340:109434.
HAN P,LUAN Y,LIU Y, et al. Small interfering RNA targeting Rac1 sensitizes colon cancer to dihydroartemisinin-induced cell cycle arrest and inhibited cell migration by suppressing NFκB activity[J]. Mol Cell Biochem,2013,379(1-2):171-180.
CHEN Y,MI Y,ZHANG X, et al. Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK/ATF4/HSPA5 pathway in glioma cells[J]. J Exp Clin Cancer Res,2019,38(1):402.
YUAN B,LIAO F,SHI Z Z, et al. Dihydroartemisinin Inhibits the Proliferation, Colony Formation and Induces Ferroptosis of Lung Cancer Cells by Inhibiting PRIM2/SLC7A11 Axis[J]. Onco Targets Ther,2020,13:10829-10840.
LIU Y,GAO S,ZHU J, et al. Dihydroartemisinin induces apoptosis and inhibits proliferation, migration, and invasion in epithelial ovarian cancer via inhibition of the hedgehog signaling pathway[J]. Cancer Med,2018,7(11):5704-5715.
MAGENTA D,SANGIOVANNI E,BASILICO N, et al. Inhibition of metalloproteinase-9 secretion and gene expression by artemisinin derivatives[J]. Acta Trop,2014,140:77-83.
LIN R Y,ZHANG Z H,CHEN L F, et al. Dihydroartemisinin(DHA)induces ferroptosis and causes cell cycle arrest in head and neck carcinoma cells[J]. Cancer Lett,2016,381(1):165-175.
QIN G Q,ZHAO C B,ZHANG L L, et al. Dihydroartemisinin induces apoptosis preferentially via a Bim-mediated intrinsic pathway in hepatocarcinoma cells[J]. Apoptosis,2015,20(8):1072-1086.
LIAO K,LI J,WANG Z L. Dihydroartemisinin inhibits cell proliferation via AKT/GSK3β/cyclinD1 pathway and induces apoptosis in A549 lung cancer cells[J]. Int J Clin Exp Pathol,2014,7(12):8684-8691.
CHEN S S,HU W,WANG Z, et al. p8 attenuates the apoptosis induced by dihydroartemisinin in cancer cells through promoting autophagy[J]. Cancer Biol Ther,2015,16(5):770-779.
LU M,SUN L H,ZHOU J, et al. Dihydroartemisinin-Induced Apoptosis is Associated with Inhibition of Sarco/Endoplasmic Reticulum Calcium ATPase Activity in Colorectal Cancer[J]. Cell Biochem Biophys,2015,73(1):137-145.
SHAO Y Y,ZHANG T L,WU L X, et al. AKT Axis, miR-21, and RECK Play Pivotal Roles in Dihydroartemisinin Killing Malignant Glioma Cells[J]. Int J Mol Sci,2017,18(2):350.
ZHANG H,ZHOU F,WANG Y Y, et al. Eliminating Radiation Resistance of Non-Small Cell Lung Cancer by Dihydroartemisinin Through Abrogating Immunity Escaping and Promoting Radiation Sensitivity by Inhibiting PD-L1 Expression[J]. Front Oncol,2020,10:595466.
ONTIKATZE T,RUDNER J,HANDRICK R, et al. Dihydroartemisinin is a Hypoxia-Active Anti-Cancer Drug in Colorectal Carcinoma Cells[J]. Front Oncol,2014,4:116.
WU C Y,ZHANG Y X,SUN Z R, et al. Molecular evolution of Cide family proteins: Novel domain formation in early vertebrates and the subsequent divergence[J]. BMC Evol Biol,2008,8(1):159.
SINGH N,HASSAN A,BOSE K. Molecular basis of death effector domain chain assembly and its role in caspase-8 activation[J]. FASEB J,2016,30(1):186-200.
YANG Y Y,YU Y B,WANG J H, et al. Silica nanoparticles induced intrinsic apoptosis in neuroblastoma SH-SY5Y cells via CytC/Apaf-1 pathway[J]. Environ Toxicol Pharmacol,2017,52:161-169.
LU W N,ZHENG F P,LAI D W, et al. Xuezhikang(血脂康)reduced renal cell apoptosis in streptozocin-induced diabetic rats through regulation of Bcl-2 family[J]. Chin J Integr Med,2016,22(8):611-618.
LARSEN B D,RAMPALLI S,BURNS L E, et al. Caspase 3/Caspase-Activated DNase Promote Cell Differentiation by Inducing DNA Strand Breaks[J]. Proc Natl Acad Sci U S A,2010,107(9):4230-4235.
SONG G,OUYANG G L,BAO S D. The activation of Akt/PKB signaling pathway and cell survival[J]. J Cell Mol Med,2005,9(1):59-71.
XIN M G,DENG X M. Nicotine Inactivation of the Proapoptotic Function of Bax through Phosphorylation[J]. J Biol Chem,2005,280(11):10781-10789.
Proliferation inhibition and apoptosis induction in human leukemia HL⁃60 cells by resveratrol via down⁃regulating SIX1
Effects of Shidao Tongjie Decoction on proliferation and apoptosis of esophageal carcinoma xenograft tumor in nude mice
Protective Effect of “Guanxinkang Decoction” on Vascular Endothelial Cells Injury Induced by Oxygenized Low Density Lipoprotein
Effects of Qiyeling Decoction on proliferation and apoptosis of paclitaxel-resistant lung cancer cell A549/Taxol
Exploration on characteristics and research progress of traditional Chinese medicine in treatment of triple⁃negative breast cancer based on tumor⁃associated macrophages
Related Author
No data
Related Institution
Department of Hematology, the Second Hospital of Hebei Medical University, Key Laboratory of Hematology in Hebei Provincial
Department of Integrated Chinese and Western Medicine,Shanghai Chest Hospital, Shanghai Jiao Tong University
College of Pharmacy, East China University of Science and Technology
Department of Cardiology, Longhua Hospital Affiliated to Shanghai University of Traditional Chinese Medicine
Central Laboratory, Shanghai Chest Hospital, Shanghai Jiao Tong University